Longfei Ma

800 total citations
30 papers, 406 citations indexed

About

Longfei Ma is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Longfei Ma has authored 30 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 14 papers in Surgery and 6 papers in Oncology. Recurrent topics in Longfei Ma's work include Esophageal Cancer Research and Treatment (10 papers), Gastric Cancer Management and Outcomes (10 papers) and Esophageal and GI Pathology (6 papers). Longfei Ma is often cited by papers focused on Esophageal Cancer Research and Treatment (10 papers), Gastric Cancer Management and Outcomes (10 papers) and Esophageal and GI Pathology (6 papers). Longfei Ma collaborates with scholars based in China and United States. Longfei Ma's co-authors include Jiaqing Xiang, Yawei Zhang, Hong Hu, Haiquan Chen, Guodong Wang, Longsheng Miao, Xiaowei Zhao, Ying Kong, Chunyang Meng and Jiaqing Xiang and has published in prestigious journals such as Polymer, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Longfei Ma

27 papers receiving 404 citations

Peers

Countries citing papers authored by Longfei Ma

Since Specialization

Citations

This map shows the geographic impact of Longfei Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longfei Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longfei Ma more than expected).

Fields of papers citing papers by Longfei Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longfei Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longfei Ma. The network helps show where Longfei Ma may publish in the future.

Co-authorship network of co-authors of Longfei Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Longfei Ma. A scholar is included among the top collaborators of Longfei Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longfei Ma. Longfei Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Inversion of Rice Leaf Pigment Content: Using the Absorption Spectrum to Optimize the Vegetation Index 2024 ·Agriculture ·Longfei Ma, (unknown), (unknown), (unknown), (unknown), (unknown), Shenghui Fang, Yan Gong	0
2	Analysis of Ion Transport Properties of Glycine max HKT Transporters and Identifying a Regulation of GmHKT1;1 by the Non-Functional GmHKT1;4 2024 ·Plant and Cell Physiology ·Liu Liu, (unknown), Longfei Ma, Yanli Zhang, (unknown), Jicheng Wang, (unknown), Shaowu Xue	4
3	Pathological features of the differentiation landscape in esophageal squamous cell cancer and their correlations with prognosis 2024 ·Frontiers in Oncology ·Jiaying Deng, Lei Zhang, Zezhou Wang, Bin Li, Jia-Qing Xiang, Longfei Ma, Hongcheng Zhu, Yuan Li, Kuaile Zhao	1
4	The G allele of SNP rs3922 reduces the binding affinity between IGF2BP3 and CXCR5 correlating with a lower antibody production 2023 ·European Journal of Immunology ·Zhaojun Duan, Longfei Ma, (unknown), (unknown), Lilin Ye, Jianguo Wu, Yunping Luo	1
5	Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9) 2023 ·Radiation Oncology ·Dashan Ai, Yun Chen, Qi Liu, Jiaying Deng, Xiaofei Zhang, Junhua Zhang, Li Chu, (unknown), Longfei Ma, Yawei Zhang, Haiquan Chen, Longsheng Miao, Kuaile Zhao, Jiaqing Xiang	3
6	959P Combination therapy of envafolimab and suvemcitug in patients with hepatocellular carcinoma (HCC): Results from a phase II clinical trial 2023 ·Annals of Oncology ·Longfei Ma, (unknown), Yu Fang, Hao Chen, Qiang Fan, (unknown), Lingeng Lu, Fei Su, Chen Yang, Zhuang Liu, Jianbo Tian, Xiaowu Sun, Sanyuan Sun, Ying Cheng	3
7	247P KN026 in combination with docetaxel as neoadjuvant treatment for HER2+ early or locally advanced breast cancer (BC): A single-arm, multicenter, phase II study 2023 ·Annals of Oncology ·Longfei Ma, Bang‐Hung Yang, Mingjie Zhang, Kun Wang, Yun Chen, Zhimin Fan, Jian Zhang, Bo Xia, Jiong Wu	2
8	Development and application of the low Curie point positive temperature coefficient (PTC) electrothermal anti-icing material 2023 ·Polymer ·(unknown), Xingliang Jiang, Yu Chen, Tao Li, Qiulin Chen, Longfei Ma	2
9	miR-137 suppresses cell growth and extracellular matrixdegradation through regulating ADAMTS-5 in chondrocytes. 2019 ·PubMed ·(unknown), Guodong Wang, Longfei Ma, Chengqun Wang, Lina Wang, Yanxia Guo, Xiaowei Zhao	13
10	Three-field versus two-field lymph node dissection for thoracic esophageal squamous cell carcinoma: a propensity score-matched comparison 2018 ·Journal of Thoracic Disease ·(unknown), Ting Ye, Longfei Ma, Dong Lin, Hong Hu, Yihua Sun, Yawei Zhang, Jiaqing Xiang	13
11	Prospection of electromagnetic navigation for hepatic ducts exploration by choledochoscope based on a three-dimensional printing model 2017 ·Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi ·Rui Tang, Longfei Ma, Jianping Zeng, (unknown), Xuedong Wang, Liang Wang, Hongen Liao	2
12	Surgical Outcomes of Isolated Malignant Pulmonary Nodules in Patients with a History of Breast Cancer 2017 ·Annals of Surgical Oncology ·(unknown), Ting Ye, Longfei Ma, Jiaqing Xiang, Haiquan Chen	10
13	Results of neoadjuvant therapy followed by esophagectomy for patients with locally advanced thoracic esophageal squamous cell carcinoma 2017 ·Journal of Thoracic Disease ·Dong Lin, Longfei Ma, Ting Ye, Yunjian Pan, (unknown), (unknown), (unknown), Haiquan Chen, Jiaqing Xiang	4
14	Splenic Artery Ligation for Iatrogenic Injury in Esophagectomy Operations 2016 ·The Annals of Thoracic Surgery ·(unknown), Ting Ye, Longfei Ma, (unknown), Dong Lin, (unknown), Jiaqing Xiang	0
15	Naringin protects human adipose-derived mesenchymal stem cells against hydrogen peroxide-induced inhibition of osteogenic differentiation 2015 ·Chemico-Biological Interactions ·(unknown), Yuge Zhang, Xiumei Wang, Longfei Ma, (unknown)	36
16	Comparison of Ivor-Lewis vs Sweet Esophagectomy for Esophageal Squamous Cell Carcinoma 2015 ·JAMA Surgery ·(unknown), Jiaqing Xiang, Yawei Zhang, Hecheng Li, Jie Zhang, Yihua Sun, Hong Hu, Longsheng Miao, Longfei Ma, Xiaoyang Luo, Sufeng Chen, Ting Ye, Yiliang Zhang, Yang Zhang, Haiquan Chen	58
17	Incidence and management of chylothorax after esophagectomy 2015 ·Thoracic Cancer ·Longsheng Miao, Yawei Zhang, Hong Hu, Longfei Ma, (unknown), Jiaqing Xiang, Haiquan Chen	59
18	Placement of laparoscopic jejunostomy for patients with esophageal cancer 2014 ·Clinical Oncology and Cancer Research ·Xiao Ma, Hecheng Li, Yiliang Zhang, Wei Guo, Longfei Ma, Jie Zhang, Jiaqing Xiang	1
19	CD44 targets Na+/H+ exchanger 1 to mediate MDA-MB-231 cells’ metastasis via the regulation of ERK1/2 2014 ·British Journal of Cancer ·Guoqiang Chang, Juan Wang, Han Zhang, (unknown), C Wang, Hua Xu, (unknown), Longfei Ma, (unknown), Tianxiang Pang	37
20	Totally minimally invasive Ivor-Lewis esophagectomy with single-utility incision video-assisted thoracoscopic surgery for treatment of mid-lower esophageal cancer 2014 ·Diseases of the Esophagus ·Wei Guo, Longfei Ma, (unknown), Xiao Ma, Sheng Yang, Xiaoli Zhu, (unknown), (unknown), Jiaqing Xiang, (unknown)	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact